- Home
- SELF vs COEP Comparison
SELF vs COEP Comparison
Compare SELF & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | COEP |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 100.4M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SELF | COEP |
|---|---|---|
| Price | $5.16 | $12.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.1K | ★ 28.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.64% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $12,530,280.00 | N/A |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $34.27 | ★ N/A |
| Revenue Growth | ★ 2.79 | N/A |
| 52 Week Low | $4.73 | $6.32 |
| 52 Week High | $5.83 | $21.41 |
Technical Indicators
Market Signals| Indicator | SELF | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 51.29 |
| Support Level | $5.02 | $10.74 |
| Resistance Level | $5.22 | $13.12 |
| Average True Range (ATR) | 0.09 | 0.84 |
| MACD | 0.02 | 0.20 |
| Stochastic Oscillator | 76.67 | 67.07 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.